Trial no.:
|
PACTR201801002991130 |
Date of Approval:
|
20/01/2018 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
oxidative stress and attention in epilepsy |
Official scientific title |
oxidative stress and attention in children with idiopathic epilepsy |
Brief summary describing the background
and objectives of the trial
|
Children with epilepsy have impaired cognitive function including attention , memory and executive function. Oxidation stress has linked to cognitive impairment in elderly, however its role in cognitive impairment in children with epilepsy is not fully explored.
The aim of the current study is to explore the association between serum level of malonaldhyde as oxidation stress marker and selective attention assessed by auditory event related potential P300 event related potential in a group of children with idiopathic epilepsy. |
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
epilepsy,Genetic Diseases,Mental and Behavioural Disorders,Paediatrics |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
20/09/2017 |
Actual trial start date |
20/09/2017 |
Anticipated date of last follow up |
31/01/2018 |
Actual Last follow-up date |
30/01/2018 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
58 |
Recruitment status |
Completed |
Publication URL |
|
|